Literature DB >> 32007152

Offline: 2019-nCoV outbreak-early lessons.

Richard Horton.   

Abstract

Entities:  

Year:  2020        PMID: 32007152      PMCID: PMC7137834          DOI: 10.1016/S0140-6736(20)30212-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
It is still too early, and available information is still too incomplete, to be certain about many aspects of the 2019 novel coronavirus (2019-nCoV) outbreak in China. However, important elements of the management of this global health emergency—and it is an emergency of major international concern—are becoming clearer. As the outbreak accelerates, there are early lessons to be learned. The transmissibility of 2019-nCoV—or at least its geographical distribution—seems to be higher and broader than initially expected. Why? Partly this may be because of China's rapid expansion of its transport networks, especially air and high-speed rail. Wuhan is a crucial hub: linking west to Chengdu, south to Guangzhou and Shenzhen, east to Nanjing and Shanghai, and north to Beijing. With much of December a period when the outbreak went unreported and unrecognised, the population exposed to the virus is far greater than first thought—a cause for heightened concern. Information is a key tool to manage the outbreak. We have received messages from Chinese journalists struggling to report accurate information from state authorities. From one Caixin journalist: “For some reason, it's very hard to get domestic experts to speak to the media now. But the public needs to hear more advice from experts.” Some observers say that independent infectious disease and public health specialists fear making public statements if those statements have not been approved by Chinese authorities. One can understand the Chinese Government's wish to manage the flow of accurate information to the public. But if that flow is being limited or is simply too little, it would be permissible, indeed surely wise, to empower specialists to speak to the media to give their advice and to allay undue public anxiety. The health response in China has been impressive, if at times it appears severe—shutting down exit and entry into cities, strict isolation, and bans on certain categories of contact. But to attack the root causes of this outbreak will require reducing risks of animal-to-human transmission. That will mean a concerted effort to close the sources of virus transmission—poorly hygienic animal wet markets. To do so will demand a huge cultural shift in Chinese society, one that should not be underestimated, but one that is essential if this type of outbreak is to be prevented in the future. To safeguard their own citizens, as well as to strengthen global health security, Chinese political leaders must clearly state their commitment to eradicating these markets. There has been an understandable focus on containing the spread of 2019-nCoV. But less attention has been given to the need for sufficient clinical capacity to deliver care to infected individuals. The viral pneumonia caused by 2019-nCoV can be extremely severe. In the first reports of patients with 2019-nCoV, a third required admission to intensive care, with the majority developing adult respiratory distress syndrome. Even high-income countries with technically advanced health systems would struggle to provide the necessary care to potentially large numbers of patients with severe complications of 2019-nCoV. China has a well developed hospital system, but the surge capacity for intensive care will be limited. What can Chinese authorities do, together with the international medical community, to expand acute medical services, including the supply of skilled hospital staff, to meet the needs of infected patients? This question is urgent. In 2003, when SARS struck, China's health research system was fragmented and poorly coordinated. Not so today. China's science community has reacted with speed and skill to investigate and report in real time the ongoing outbreak, providing critical public health, clinical, and virological data to guide the national and global response. Research is sometimes seen as a luxury when countries are being urged to invest in basic primary health care. But the 2019-nCoV outbreak has shown the foundational importance of research for any effective public health response. When this latest outbreak has been contained, WHO, with the support of member states, must redouble its efforts to make health research an integral part of universal health coverage. The 2019-nCoV outbreak proves that health research saves lives.
  16 in total

1.  Administrative Mechanism of Joint Participation and Cooperation in the Early Stages of the COVID-19 Outbreak in Wuhan.

Authors:  Jingjing Yan; Dahai Zhao
Journal:  Risk Manag Healthc Policy       Date:  2020-07-06

2.  Consideration of the respiratory support strategy of severe acute respiratory failure caused by SARS-CoV-2 infection in children.

Authors:  Giuseppe A Marraro; Claudio Spada
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-03

Review 3.  SARS-CoV-2: characteristics and current advances in research.

Authors:  Yicheng Yang; Zhiqiang Xiao; Kaiyan Ye; Xiaoen He; Bo Sun; Zhiran Qin; Jianghai Yu; Jinxiu Yao; Qinghua Wu; Zhang Bao; Wei Zhao
Journal:  Virol J       Date:  2020-07-29       Impact factor: 4.099

4.  Epidemiology of Coronavirus Disease in Gansu Province, China, 2020.

Authors:  Jingchun Fan; Xiaodong Liu; Weimin Pan; Mark W Douglas; Shisan Bao
Journal:  Emerg Infect Dis       Date:  2020-06-17       Impact factor: 6.883

5.  Health policy and technology challenges in responding to the COVID-19 pandemic.

Authors:  Donald Rj Singer
Journal:  Health Policy Technol       Date:  2020-04-30

6.  Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues.

Authors:  Meng-Yuan Li; Lin Li; Yue Zhang; Xiao-Sheng Wang
Journal:  Infect Dis Poverty       Date:  2020-04-28       Impact factor: 4.520

7.  Updates on Wuhan 2019 novel coronavirus epidemic.

Authors:  Foster Kofi Ayittey; Christian Dzuvor; Matthew Kormla Ayittey; Nyasha Bennita Chiwero; Ahmed Habib
Journal:  J Med Virol       Date:  2020-02-10       Impact factor: 2.327

8.  Toning down the 2019-nCoV media hype-and restoring hope.

Authors:  Giuseppe Ippolito; David S Hui; Francine Ntoumi; Markus Maeurer; Alimuddin Zumla
Journal:  Lancet Respir Med       Date:  2020-02-12       Impact factor: 30.700

9.  Epidemiological Characteristics and Clinical Outcomes of Coronavirus Disease Patients in Northwest China: High-Volume Research From Low Population Density Regions.

Authors:  Jianfei Zhu; Qingqing Zhang; Chenghui Jia; Wuping Wang; Jiakuan Chen; Yanmin Xia; Wenchen Wang; Xuejiao Wang; Miaomiao Wen; Hongtao Wang; Zhipei Zhang; Shuonan Xu; Jinbo Zhao; Tao Jiang
Journal:  Front Med (Lausanne)       Date:  2020-10-30

10.  The COVID-19 Infodemic: Infodemiology Study Analyzing Stigmatizing Search Terms.

Authors:  Zhiwen Hu; Zhongliang Yang; Qi Li; An Zhang
Journal:  J Med Internet Res       Date:  2020-11-16       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.